Nanexa AB (publ) (STO:NANEXA)

Market Cap	364.03M
Revenue (ttm)	40.31M
Net Income (ttm)	-31.07M
Shares Out	156.91M
EPS (ttm)	-0.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,580,220
Average Volume	643,107
Open	2.320
Previous Close	2.320
Day's Range	2.320 - 2.540
52-Week Range	0.701 - 3.150
Beta	1.87
RSI	69.85
Earnings Date	Aug 27, 2025

About Nanexa AB

Nanexa AB (publ) operates as a nanotechnology drug delivery company. The company operates PharmaShell, a drug delivery system that is an atomic layer deposition. It also develops NEX-22 for the treatment of type 2 diabetes. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Employees: 13
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NANEXA

Financial Performance

In 2024, Nanexa AB's revenue was 46.69 million, a decrease of -21.07% compared to the previous year's 59.16 million. Losses were -24.91 million, -67.40% less than in 2023.